Syncona Commences Tender Offer for All Outstanding Shares of Applied Genetic Technologies Corporation
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies…
Month: October 2022
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines…
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
Alvotech (NASDAQ: ALVO), a global biotech specialized in the development and manufacture of biosimilar medicines…
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech…
Alvotech to Participate in Upcoming Jefferies London Healthcare Conference in November
REYKJAVIK, Iceland , Oct. 26, 2022 (GLOBE NEWSWIRE) — Alvotech (NASDAQ: ALVO), a global biotech…
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million…
ObsEva Announces Progress on Cost Reduction Initiatives and Stay of Moratorium Proceedings
Transition of linzagolix program to Kissei Pharmaceutical Co., Ltd. substantially complete with approximately $16.0 million…
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
ROCKVILLE, MD, Oct. 26, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
ROCKVILLE, MD, Oct. 26, 2022 (GLOBE NEWSWIRE) — MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company…
Travere Therapeutics Announces Presentations and Posters at American Society of Nephrology Kidney Week 2022
Data support the Company’s lead investigational product candidate sparsentan SAN DIEGO, Oct. 26, 2022 (GLOBE…
Travere Therapeutics Announces Presentations and Posters at American Society of Nephrology Kidney Week 2022
Data support the Company’s lead investigational product candidate sparsentan SAN DIEGO, Oct. 26, 2022 (GLOBE…
Terns Pharmaceuticals to Present Positive Clinical Data in NASH at AASLD The Liver Meeting® 2022
FOSTER CITY, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Terns Pharmaceuticals to Present Positive Clinical Data in NASH at AASLD The Liver Meeting® 2022
FOSTER CITY, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the…
Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022
SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
Myriad Genetics to Release Third-Quarter Financial Results on Nov. 1, 2022
SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a…
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022
FREMONT, Calif., Oct. 26, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022
4D Molecular Therapeutics to host a conference call on November 3rd, 4:30 pm E.T. EMERYVILLE,…
4D Molecular Therapeutics Interim Clinical Data from the On-going Phase 1/2 Clinical Trial of 4D-710 for Cystic Fibrosis Lung Disease to be Presented at NACFC 2022
4D Molecular Therapeutics to host a conference call on November 3rd, 4:30 pm E.T. EMERYVILLE,…
COMPASS Pathways plc to announce third quarter 2022 financial results on 3 November 2022
LONDON, Oct. 26, 2022 (GLOBE NEWSWIRE) — COMPASS Pathways plc (Nasdaq: CMPS), a mental health…